Navigation Links
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Date:5/21/2012

MALVERN, Pa., May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is raising its full year 2012 revenue guidance to a range of $293 to $315 million and is reducing its guidance for net loss to a range of $5 to $10 million.  The Company will be holding a conference call today, May 21, 2012, at 10:00 am ET to discuss the agreement for the Testim® U.S. co-promotion with GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (LSE: GSK).

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

The Company's previous and revised full year 2012 financial guidance is ($ millions):  PreviousRevisedTotal Revenue$283 - $305$293 - $315Global Testim Revenues$215 - $225$225 - $235Xiaflex:U.S. Revenues$55 - $65$55 - $65  Ex-U.S. / Def. Rev$13 - $15$13 - $15Total XIALEX$68 - $80$68 - $80R&D Expense$55 - $65$55 - $65S G & A Expense$180 - $190$180 - $190Net Income (Loss)$(5) - $(15)$(5) - $(10) "As a result of this morning's announcement concerning the Testim U.S. co-promotion agreement, we are increasing Testim revenue guidance and trimming net loss guidance for 2012,"  said Jim Fickenscher, Chief Financial Officer of Auxilium.  "While we have not changed our previously stated guidance for Selling, General & Administrative expense, it is likely that we will be near the top end of the range."

Conference Call
The presentation slides to be used during the call will be available on the "For Investors" section of the Company's web site under the "Presentations" tab at 10:00 a.m. ET.  A question and answer session will follow the presentation.  The conference call and the presentation slides will be simultaneously web cast on the "For Investors" section of the Company's web site under the "Events" tab
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
(Date:7/24/2014)... IRVING, Texas , July 24, 2014 /PRNewswire/ ... in the cardiovascular market that could impact patient ... Spring 2014 CV Watch , "Innovations in ... report provides hospitals with guidance and details on ... serve patient needs and understand how these options ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
(Date:7/24/2014)... semen is naturally colonized by bacteria, and a new study ... both HIV transmission and levels in infected men. U.S. ... play a role in local inflammation and in the production ... to possible targets for reducing transmission of the AIDS-causing virus. ... changes in HIV levels, and the researchers say more research ...
(Date:7/24/2014)... the body,s own immune system play a role in ... chronic epilepsy, Alzheimer,s dementia and concussions? Cleveland Clinic researchers ... PLOS ONE . , The study focuses on ... serves as a biomarker for brain damage. Normally, S100B ... However, following a brain injury, it can leak through ...
(Date:7/24/2014)... to transform into an aggressive form of cancer, are ... the metastasis or, even better, prevent their formation would ... Researchers at Universit catholique de Louvain (Belgium) successfully performed ... mice. The results of their study are published ... Cell Reports . , The work by Professor Pierre ...
(Date:7/24/2014)... prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, ... United States. Many children with this abnormality are ... few years of life with the hopes of ... recently, however, little evidence existed as to the ... and inconvenience for families. But a study published ...
(Date:7/24/2014)... The Biofeedback Federation of Europe is ... game development company Zukor Interactive. The agreement provides ... Zukor's Grind , a next-generation feedback game ... and international markets. , Zukor's Grind is a ... as a biofeedback/neurofeedback training tool. Typical training provides ...
Breaking Medicine News(10 mins):Health News:Bacteria in Semen May Affect HIV Transmission, Levels: Study 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:A world first: Researchers identify a treatment that prevents tumor metastasis 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 2Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 3
... chromosome lineage reveals farming influence , TUESDAY, Jan. 19 (HealthDay ... farmers who migrated from the Near East 10,000 years ago, ... Y chromosome, which is passed from father to son. , ... by about 110 million men -- it follows a gradient ...
... A.M. , Justin Herman Plaza , Market ... www.walkforlifewc.c o m , Speakers and organizers are available ... A woman who walked away from her job as a clinic director at ... on exposing abuses in the abortion industry will speak at the 6th Annual Walk ...
... , MIDLAND, ... adopt lifelong healthy behaviors with Health Enhancement Systems, ( ... The online program, 5 on 5 ( www.5on5.com ... habits wrapped in an exciting basketball tournament format. Participants form teams of ...
... , STRATHAM, N.H. ... world,s leading producer of premium chocolate, announces it is accepting nominations for ... the second year, Lindt will honor ordinary individuals who are extraordinary champions ... Lindt Unsung Heroes of Autism program is part of Lindt,s partnership with ...
... ,greater than, problems, study suggests , TUESDAY, Jan. 19 ... math? , A German team of neurobiologists has found ... using specific brain cells dedicated to the comprehension of ... insight into the neurology behind human ability to comprehend ...
... , TAMPA, Fla. , Jan. 19 ... Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is ... coverage of the recommended childhood obesity treatments. , The recommendations ... in moderate to intensive programs helps children affected by obesity ...
Cached Medicine News:Health News:6th Annual Walk for Life West Coast Saturday, January 23, 2010 2Health News:Corporate Teams Score Points for Healthy Eating 2Health News:Corporate Teams Score Points for Healthy Eating 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 2Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 4Health News:Monkey Brain 'Hardwired' for Simple Math 2Health News:Monkey Brain 'Hardwired' for Simple Math 3Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: